Cognitive Dysfunction in Bipolar Disorder A Guide for Clinicians

A growing body of clinical and experimental evidence shows that neurocognitive dysfunction is a fundamental yet frequently ignored or misidentified component of bipolar disorder. The first comprehensive book of its kind, Cognitive Dysfunction in Bipolar Disorder: A Guide for Clinicians compiles the latest data in neuropsychology, neuroimaging, neurogenetics, and functional outcomes research to enable clinicians to more effectively utilize pharmacological and psychotherapeutic techniques in their treatment of bipolar disorder.

This volume outlines and demystifies current knowledge about neuropsychological functioning in bipolar disorder in a reader-friendly, easy-to-understand guide for practitioners. Its 12 chapters, written by 23 internationally-renowned expert contributors, examine such topics as attentional and executive functioning, neuroimaging and genetic correlates of cognitive functioning, pharmacologic strategies, bipolar disorder in pediatric patients, and cognition across the life span. The book also includes helpful bulleted take-home points at the end of each chapter that summarize main concepts, as well as case vignettes and illustrative examples that depict the clinical application of specific neurocognitive principles.

Using relevant applications from cognitive neuroscience, Cognitive Dysfunction in Bipolar Disorder provides clinicians with a comprehensive overview of astounding breakthroughs in the assessment and treatment of patients with bipolar disorder. It plows new ground in the mental health industry, correcting distortions and laying the foundation for future clinical research in this rapidly expanding field.

Joseph F. Goldberg, M.D., is Associate Clinical Professor of Psychiatry at Mount Sinai School of Medicine in New York, New York; and Director of the Affective Disorders Research Program at Silver Hill Hospital in New Canaan, Connecticut.

Katherine E., Burdick, Ph.D., is Assistant Professor of Psychiatry at Albert Einstein College of Medicine in The Bronx, New York; and Director of the Neurocognitive Assessment Unit in the Division of Psychiatry Research of The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, in Glen Oaks, New York.